Shah Amar J, Althobiani Malik A, Saigal Anita, Ogbonnaya Chibueze E, Hurst John R, Mandal Swapna
Royal Free London NHS Foundation Trust, London, UK.
UCL Respiratory, University College London, London, UK.
NPJ Digit Med. 2023 Nov 27;6(1):222. doi: 10.1038/s41746-023-00962-0.
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death and is associated with multiple medical and psychological comorbidities. Therefore, future strategies to improve COPD management and outcomes are needed for the betterment of patient care. Wearable technology interventions offer considerable promise in improving outcomes, but prior reviews fall short of assessing their role in the COPD population. In this systematic review and meta-analysis we searched ovid-MEDLINE, ovid-EMBASE, CINAHL, CENTRAL, and IEEE databases from inception to April 2023 to identify studies investigating wearable technology interventions in an adult COPD population with prespecified outcomes of interest including physical activity promotion, increasing exercise capacity, exacerbation detection, and quality-of-life. We identified 7396 studies, of which 37 were included in our review. Meta-analysis showed wearable technology interventions significantly increased: the mean daily step count (mean difference (MD) 850 (494-1205) steps/day) and the six-minute walk distance (MD 5.81 m (1.02-10.61 m). However, the impact was short-lived. Furthermore, wearable technology coupled with another facet (such as health coaching or pulmonary rehabilitation) had a greater impact that wearable technology alone. Wearable technology had little impact on quality-of-life measures and had mixed results for exacerbation avoidance and prediction. It is clear that wearable technology interventions may have the potential to form a core part of future COPD management plans, but further work is required to translate this into meaningful clinical benefit.
慢性阻塞性肺疾病（COPD）是第三大致死原因，且与多种医学和心理合并症相关。因此，需要制定未来战略以改善COPD的管理和治疗效果，从而提高患者护理质量。可穿戴技术干预措施在改善治疗效果方面具有很大潜力，但以往的综述未能评估其在COPD患者群体中的作用。在这项系统综述和荟萃分析中，我们检索了从创刊至2023年4月的ovid-MEDLINE、ovid-EMBASE、CINAHL、CENTRAL和IEEE数据库，以识别研究可穿戴技术干预措施对成年COPD患者群体影响的研究，这些研究具有预先设定的感兴趣的结果，包括促进身体活动、提高运动能力、检测病情加重情况以及生活质量。我们共识别出7396项研究，其中37项被纳入我们的综述。荟萃分析表明，可穿戴技术干预措施显著增加了：平均每日步数（平均差值（MD）为850（494 - 1205）步/天）和六分钟步行距离（MD为5.81米（1.02 - 10.61米））。然而，这种影响是短暂的。此外，可穿戴技术与其他方面（如健康指导或肺康复）相结合比单独使用可穿戴技术的影响更大。可穿戴技术对生活质量指标影响甚微，在避免和预测病情加重方面结果不一。显然，可穿戴技术干预措施有可能成为未来COPD管理计划的核心组成部分，但需要进一步开展工作将其转化为有意义的临床益处。
